Neuroimaging and Proteomic Tracking of Neurodegeneration in MPTP‐Treated Mice
Howard E. Gendelman(Nebraska Medical Center), R. Lee Mosley(University of Nebraska Medical Center), Christopher J. Destache(Creighton University), MICHAEL K. McCARTHY(University of Nebraska Medical Center), Toni M. Biskup(University of Nebraska Medical Center), CRAIG NEMECHEK(University of Nebraska Medical Center), Eric J. Benner(Duke University), Jay A. Nelson(Oregon Health & Science University), Marina Zelivyanskaya(University of Nebraska Medical Center), Michael D. Boska(Nebraska Medical Center), Kimberly A. Carlson(University of Nebraska–Lincoln)
Cited by 2
Related Papers
Diagnostics for SARS-CoV-2 infections
|Nature Materials|2021|838
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease
|The Journal of Immunology|2010|412
Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
|Clinical Neuroscience Research|2006|390
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
|PLoS ONE|2008|363
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
|Proceedings of the National Academy of Sciences|2004|319